Tecar Therapy in Chronic Knee Osteoarthritis
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Tecar Therapy, ShamTecar Therapy, conventional physical therapy.
- Who it may be relevant to
- Registry conditions: Osteearthritis. Basic parameters: 40 years — 75 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Turkey (Türkiye)
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Effects of Tecar Therapy (Targeted Radiofrequency Therapy) on Pain, Physical Function, and Physical Capacity in Patients With Chronic Knee Osteoarthritis: A Randomized Controlled Trial
Overview
This study aimed to investigate the effects of Tecar therapy on pain, physical function, and physical capacity in patients with chronic knee osteoarthritis.
Detailed description
Knee osteoarthritis is a degenerative, inflammatory, and chronic joint disease with an increasing incidence and prevalence worldwide. By causing pain, disability, and deterioration in quality of life, it constitutes a significant public health problem globally. Furthermore, the health, social, and economic burdens associated with chronic knee osteoarthritis are expected to increase in the future. For these reasons, and due to the rising incidence of the disease, clinicians are increasingly focusing on novel treatment strategies.
Currently, both surgical and non-surgical treatment modalities are used in the management of chronic knee osteoarthritis. The cornerstone of treatment consists of patient education, exercise, and weight control. Subsequent steps include pharmacological treatments, intra-articular injections, and physical therapy modalities. These modalities include transcutaneous electrical stimulation, therapeutic ultrasound, thermal modalities, laser therapy, extracorporeal shock wave therapy, electromagnetic field therapy, and capacitive and resistive electric transfer (Tecar therapy).
Tecar therapy is an endogenous diathermy modality that operates in the long-wave range using radiofrequency energy of approximately 0.5 MHz to heat the treated tissues. It consists of two electrodes-capacitive and resistive-with a long-wave current generator and multi-frequency sequential emission systems that deliver energy to tissues in two different modes. In the capacitive mode, an insulated electrode with a metal plate is generally used. The electrical charges generated by the radiofrequency generator accumulate near the insulated electrode, which acts as a dielectric surface. This method is used for the treatment of superficial tissues adjacent to the insulated electrode. In the resistive mode, two metal electrodes distribute electrical charges that tend to accumulate near bone, tendon, and connective tissue.
Tecar therapy has been shown to have positive effects on pain and quality of life in many patients with degenerative and inflammatory orthopedic conditions. Among diathermy modalities, Tecar therapy is considered one of the most appropriate and safe methods, as-unlike ultrasound-it has no limitation in terms of treatment area and does not cause excessive heat accumulation between the skin and the electrode .
To the best of our knowledge, there are very few studies investigating the use of Tecar therapy in chronic knee osteoarthritis. Therefore, the aim of this study was to investigate the effects of Tecar therapy on pain, physical function, and physical capacity in patients with chronic knee osteoarthritis.
Interventions
- Other Tecar Therapy
Tecar Therapy and conventional physical therapy - Other ShamTecar Therapy
ShamTecar Therapy and conventional physical therapy - Other conventional physical therapy
conventional physical therapy
Primary outcome measures
- Visual Analog Scale [Time frame: baseline, 3th week, 12th week]
Secondary outcome measures (2)
- WOMAC [Time frame: baseline, 3th week, 12th week]
- The 6-minute walk test (6MWT) [Time frame: baseline, 3th week, 12th week]
Eligibility criteria
Inclusion criteria
- Patients with Kellgren-Lawrence stage 2 or 3 knee osteoarthritis
- Patients with bilateral knee pain for at least 6 weeks
- Male and female patients aged 40-75
- Patients who accept and sign the informed consent form
Exclusion criteria
- Those who have received physical therapy for knee pain in the last 6 months
- Those who have received intraarticular injection treatments such as hyaluronic acid, PRP, or steroids for knee pain in the last 6 months
- Those who have undergone knee surgery for any reason
- Those with inflammatory arthritis
- Those with existing neurological, cognitive, or psychiatric disorders
- Those with pacemakers
- Those with a history of malignancy
- Those with local vascular or sensory impairment
- Those with local or systemic infections
- Those with open wounds on the skin
- Pregnant or breastfeeding
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Double blind
- Primary purpose
- Treatment
Study locations
Turkey (Türkiye) · 1 center
- Kırşehir Ahi Evran Üniversitesi — Kırşehir
Publications
- Coccetta CA, Sale P, Ferrara PE, Specchia A, Maccauro G, Ferriero G, Ronconi G. Effects of capacitive and resistive electric transfer therapy in patients with knee osteoarthritis: a randomized controlled trial. Int J Rehabil Res. 2019 Jun;42(2):106-111. doi: 10.1097/MRR.0000000000000324. PMID 30362981
- Elboim-Gabyzon M, Nahhas F. Laser therapy versus pulsed electromagnetic field therapy as treatment modalities for early knee osteoarthritis: a randomized controlled trial. BMC Geriatr. 2023 Mar 16;23(1):144. doi: 10.1186/s12877-022-03568-5. PMID 36922781
Identifiers
NCT: NCT07438392 · AhiEvranU-FTR-NK-Tecar